셀트리온제약
068760KOSDAQ· 의료용 물질 및 의약품 제조업39,500원+400 (+1.02%)지연장중 · 갱신 대기
52주 위치
37,00078,3006%신고가 대비 -49.55%
- 시가총액
- 1.8조1조 7,539억
- PER
- 40.43
- PBR
- 3.90
- EPS(TTM)
- 977원
- BPS
- 10,117원
- 배당수익률
- 0.51%
- 자사주비율
- 0.32%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021(별도) | 2022(별도) | 2023(별도) | 2024(별도) | 2025(별도) |
|---|---|---|---|---|---|
| ROE | 10.42% | 7.54% | 5.80% | 5.68% | 9.31% |
| ROA | 5.42% | 4.20% | 3.43% | 3.35% | 5.42% |
| 영업이익률 | 11.99% | 9.89% | 9.28% | 7.79% | 10.46% |
| 순이익률 | 8.67% | 6.72% | 5.47% | 4.60% | 7.22% |
| 매출총이익률 | 29.91% | 29.21% | 30.79% | 25.53% | 30.53% |
| 부채비율 | 92.15% | 68.09% | 70.35% | 68.66% | 74.20% |
| 유동비율 | 127.40% | 147.13% | 146.32% | 158.16% | 165.92% |
| 매출 성장률(YoY) | — | -3.18% | 0.71% | 22.90% | 12.26% |
| 영업이익 성장률(YoY) | — | -20.14% | -5.50% | 3.19% | 50.69% |
| 순이익 성장률(YoY) | — | -24.93% | -18.09% | 3.30% | 76.42% |
| FCF | 821억 | -79.43억 | 37.99억 | 516억 | 703억 |
| FCF 마진 | 20.59% | -2.06% | 0.98% | 10.81% | 13.10% |
| CAPEX/매출 | 2.77% | 1.01% | 1.28% | 1.03% | 3.01% |
| 항목 | 2021 3Q(별도) | 2021 4Q(별도) | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q(별도) | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q(별도) | 2026 1Q(별도) | 2026 2Q(별도) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.74% | 1.54% | 1.29% | 2.21% | 2.35% | 1.80% | 1.94% | 2.96% | 0.91% | 0.19% | 0.52% | 1.49% | 2.16% | 1.60% | 1.88% | 2.79% | 2.81% | 2.13% | 2.11% | 3.18% |
| ROA | 1.49% | 0.80% | 0.70% | 1.27% | 1.33% | 1.00% | 1.09% | 1.74% | 0.53% | 0.11% | 0.30% | 0.89% | 1.28% | 0.95% | 1.12% | 1.62% | 1.64% | 1.24% | 1.22% | 1.82% |
| 영업이익률 | 14.31% | 6.90% | 8.74% | 10.30% | 12.97% | 6.91% | 10.62% | 13.40% | 7.02% | 5.45% | 3.80% | 8.04% | 10.65% | 7.72% | 9.54% | 11.82% | 11.66% | 8.89% | 9.76% | 12.59% |
| 순이익률 | 9.82% | 4.13% | 4.81% | 7.16% | 7.66% | 7.03% | 7.43% | 9.58% | 3.54% | 0.75% | 1.95% | 4.77% | 6.46% | 4.58% | 6.51% | 8.45% | 8.29% | 5.75% | 6.67% | 8.95% |
| 매출총이익률 | 32.98% | 25.64% | 28.51% | 27.59% | 32.71% | 27.74% | 31.03% | 32.40% | 31.51% | 28.00% | 24.68% | 25.27% | 26.64% | 25.33% | 29.67% | 31.08% | 30.83% | 30.43% | 29.74% | 33.01% |
| 부채비율 | 83.17% | 92.15% | 83.83% | 73.90% | 70.00% | 68.09% | 71.68% | 67.67% | 71.22% | 70.35% | 69.78% | 67.93% | 67.33% | 68.66% | 68.01% | 75.75% | 74.90% | 74.20% | 76.81% | 73.46% |
| 유동비율 | 129.78% | 127.40% | 128.48% | 134.19% | 144.39% | 147.13% | 144.39% | 149.28% | 146.27% | 146.32% | 144.68% | 150.07% | 158.35% | 158.16% | 160.68% | 156.84% | 161.49% | 165.92% | 164.52% | 171.40% |
| 매출 성장률(YoY) | — | — | — | — | 14.19% | -28.69% | 1.41% | 4.61% | -10.03% | 8.01% | 7.73% | 6.27% | 37.21% | 42.49% | 16.04% | 12.07% | 7.84% | 13.88% | 17.42% | 16.75% |
| 영업이익 성장률(YoY) | — | — | — | — | 3.53% | -28.61% | 23.12% | 36.06% | -51.34% | -14.73% | -61.39% | -36.25% | 108.29% | 101.73% | 191.01% | 64.80% | 18.03% | 31.11% | 20.16% | 24.37% |
| 순이익 성장률(YoY) | — | — | — | — | -10.94% | 21.44% | 56.65% | 40.00% | -58.47% | -88.55% | -71.74% | -47.07% | 150.67% | 775.15% | 287.23% | 98.33% | 38.41% | 43.15% | 20.44% | 23.74% |
| FCF | 283억 | 252억 | -168억 | -148억 | -47.36억 | 137억 | 57.55억 | 8.38억 | -309억 | 281억 | 181억 | -134억 | 191억 | 279억 | 360억 | 89.26억 | 214억 | 39.92억 | 308억 | -64.89억 |
| FCF 마진 | 31.14% | 20.42% | -18.92% | -14.04% | -4.56% | 15.58% | 6.39% | 0.76% | -33.04% | 29.49% | 18.62% | -11.45% | 14.89% | 20.59% | 31.95% | 6.80% | 15.48% | 2.59% | 23.28% | -4.23% |
| CAPEX/매출 | 1.01% | 2.72% | 1.28% | 3.70% | 5.96% | 8.31% | 0.56% | 1.58% | 1.79% | 1.09% | 0.62% | 1.20% | 0.82% | 1.39% | 5.71% | 3.38% | 1.48% | 2.10% | 2.33% | 2.51% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 07:38· 별도 · 산식은 항목 툴팁